September 8, 2014

Component resolved diagnosis: when should it be used?

Email updates

Keep up to date with the latest news and content from Clinical and Translational Allergy and BioMed Central.

Open AccessReview

Component resolved diagnosis: when should it be used?

Olga Luengo and Victòria Cardona

Citation

Abstract (provisional)

The knowledge on molecular allergy diagnosis is continuously evolving. It is now time for the clinician to integrate this knowledge and use it when needed to improve the accuracy of diagnosis and thus provide more precise therapeutic and avoidance measures. This review does not intend to comprehensively analyze all the available allergen molecules, but to provide some practical clues on use and interpretation of molecular allergy diagnosis. The potential role of component resolved diagnosis in circumstances such as the indication of allergen immunotherapy, pollen polysensitization, food allergy, latex allergy or anaphylaxis, is assessed. Interpreting the information provided by molecular allergy diagnosis needs a structured approach. It is necessary to evaluate single positivities and negativities, but also to appraise "the big picture" with perspective.

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.


No comments:

Post a Comment